 |
 |
|
|
|
RESÚMENES MAYO 2010 |
Antipsicóticos
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o estudio
aleatorizado; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3! - Learning and
Generalization in
Schizophrenia: Effects of Disease and Antipsychotic Drug Treatment
Daphna Shohamy, Perry
Mihalakos, Ronald Chin,
Binu Thomas, Anthony D. Wagner and Carol Tamminga
Biological
Psychiatry. Volume 67,
Issue 10, 15 May 2010, Pages 926-932
3! - The
Number Needed to Treat for All-Cause Medication
Discontinuation in the Treatment of Schizophrenia: Consistency Across
World
Geographies and Study Designs
D. Novick,
H. Ascher-Svanum,
B. Zhu, A. Brnabic, V. Stauffer, X. Peng,
J. Karagianis, E. Perrin
Pharmacopsychiatry
2010; 43(3): 81-85
3 - Effects of sub-chronic clozapine
and haloperidol administration on brain lipid
levels
Vilte E. Barakauskas,
Athena R. Ypsilanti,
Alasdair M. Barr, Sheila M. Innis, William G. Honer and Clare L. Beasley
3! - Interaction of
haloperidol plasma level and
antipsychotic effect in early phases of acute psychosis treatment
Ina Giegling, Antonio
Drago, Martin Schäfer,
Hans-Jürgen Möller, Dan Rujescu and Alessandro Serretti
Journal of
Psychiatric Research. Volume 44,
Issue 8, June 2010, Pages 487-492
3! - Relationship between
body mass index and insulin
resistance in patients treated with second generation antipsychotic
agents
Sun H. Kim, Lilla
Nikolics, Fahim Abbasi,
Cindy Lamendola, James Link, Gerald M. Reaven and Steven Lindley
Journal of
Psychiatric Research. Volume 44,
Issue 8, June 2010, Pages 493-498
3! -
Effectiveness of Medications Used to Attenuate Antipsychotic-Related
Weight Gain and Metabolic Abnormalities: A Systematic Review and
Meta-Analysis
Lawrence Maayan,
Julia Vakhrusheva and Christoph
U Correll
Neuropsychopharmacology
(2010) 35, 1520–1530
5 - A Randomized, Double-Blind, Placebo-Controlled Study of 2
Dose Ranges
of Paliperidone Extended-Release in the Treatment of Subjects With
Schizoaffective Disorder
Carla M.
Canuso, Jean-Pierre Lindenmayer, Colette Kosik-Gonzalez, Ibrahim
Turkoz,
Jennifer Carothers, Cynthia A. Bossie, and Nina R. Schooler
J Clin
Psychiatry 2010;71(5):587–598
5 - Adjuvant
Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum
Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled
Trial
Wijnand Laan,
Diederick E. Grobbee, Jean-Paul Selten, Cobi J. Heijnen, René S. Kahn,
and
Huibert Burger
J Clin
Psychiatry 2010;71(5):520–527
3! - Body weight gain induced
by atypical
antipsychotics: an extension of the monocygotic twin and sib pair study
S. Gebhardt, F.
M. Theisen,
M. Haberhausen, M. Heinzel-Gutenbrunner,
P. M. Wehmeier,
J.-C. Krieg, W. Kühnau, J. Schmidtke, H. Remschmidt and J. Hebebrant
Journal of
Clinical Pharmacy and Therapeutics.
Volume
35 Issue 2, Pages 207 - 211
3 - Norzotepine, a Major
Metabolite of Zotepine,
Exerts Atypical Antipsychotic-Like and Antidepressant-Like Actions
through Its
Potent Inhibition of Norepinephrine Reuptake
M. Shobo, Y.
Kondo, H.
Yamada, T.
Mihara, N.
Yamamoto, M. Katsuoka,
K. Harada, K.
Ni and N.
Matsuoka
JPET June 2010 vol. 333
no. 3 772-781
3 - Effect of
CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the
Pharmacokinetics of Risperidone and Its Active Moiety
Qian Xiang,
MS, Xia Zhao, MS, Ying Zhou, MS, Jing Li Duan, MS and Yi Min Cui
J Clin
Pharmacol 2010 50: 659 -666
3! -
Comparison of Intramuscular Olanzapine, Orally Disintegrating
Olanzapine Tablets, Oral Risperidone Solution, and Intramuscular
Haloperidol in
the Management of Acute Agitation in an Acute Care Psychiatric Ward in
Taiwan
Hsu, Wen-Yu; Huang,
Si-Sheng; Lee, Bo-Shyan; Chiu, Nan-Ying
Journal of
Clinical Psychopharmacology: June 2010 - Volume 30 - Issue 3
- pp 230-234
5 - A
Randomized, Placebo-Controlled Study to Assess the Efficacy and
Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely
Exacerbated
Schizophrenia
Pandina,
Gahan J; Lindenmayer, Jean-Pierre; Lull, Julia; Lim, Pilar; Gopal,
Srihari;
Herben, Virginie; Kusumakar, Vivek; Yuen, Eric; Palumbo, Joseph
Journal of
Clinical Psychopharmacology: June 2010 - Volume 30 - Issue 3
- pp 235-244
4 - Early
Onset of Antipsychotic Action in Schizophrenia: Evaluating the
Possibility of Shorter Acute Efficacy Trials
Kinon, Bruce J; Chen,
Lei; Stauffer, Virginia L; Sniadecki, Jennifer;
Ascher-Svanum, Haya; Kollack-Walker, Sara; Jacob, Jayanthi; Kapur,
Shitij
Journal of
Clinical Psychopharmacology: June 2010 - Volume 30 - Issue 3
- pp 286-289
3< - Transcranial magnetic
stimulation for
auditory hallucination in severe schizophrenia: Partial efficacy and
acute
elevation of sympathetic modulation
I-Ching Lai, Cheryl
C. H. Yang, Terry
B. J. Kuo, and Kun-Ruey Shieh
Psychiatry
and Clinical Neurosciences. Volume 64
Issue 3, Pages 333 - 335
5 - Paliperidone palmitate,
a potential
long-acting treatment for patients with schizophrenia. Results of a
randomized,
double-blind, placebo-controlled efficacy and safety study
Michelle Kramer, Robert
Litman, David Hough, Rosanne Lane, Pilar Lim,
Yanning Liu and Mariëlle Eerdekens
The
International Journal of Neuropsychopharmacology (2010), 13:635-647
5 - Aripiprazole in
schizophrenia and
schizoaffective disorder: A review
Emmanuel Stip and Valérie
Tourjman
Clinical
Therapeutics. Volume 32, Supplement 1, 2010, Pages S3-S20
3 - The Effect of
Antipsychotic Medication on
Neuromotor Abnormalities in Neuroleptic-Naive Nonaffective Psychotic
Patients: A
Naturalistic Study With Haloperidol, Risperidone, or Olanzapine
Victor Peralta,
and Manuel J. Cuesta
Prim Care
Companion J Clin Psychiatry 2010;12(2):e1-e11
3! - To
medicate or not to medicate, when diagnosis is in question:
decision-making in first episode psychosis
Gin
Malhi
Australasian
Psychiatry. June 2010, Vol. 18, No. 3, Pages 230-237
3 -
Avoidance-Suppressing Effect of Antipsychotic Drugs is Progressively
Potentiated after Repeated Administration: an Interoceptive Drug State
Mechanism
Ming Li and Alexa Mead
J
Psychopharmacol. First published on March 27, 2009
3 -
Extrastriatal dopamine D2 receptor occupancy in
olanzapine-treated patients with schizophrenia
Ryosuke Arakawa,
Hiroshi Ito, Masaki Okumura, Akihiro Takano,
Hidehiko Takahashi, Harumasa Takano, Yoshiro Okubo and
Tetsuya Suhara
3! - Metabolic
parameters in patients treated with olanzapine or other
atypical antipsychotics
Olawale O. Osuntokun,
Brian Millen, Wen I Xu, Ludmila A Kryzhanovskaya,
Carol Robertson-Plouch, Janice L Carlson, Nayan Acharya, and Sara A
Corya
Journal of
Psychopharmacology. First published on May 24, 2010
3! - Low
Treatment Adherence with Antipsychotics is Associated with Relapse in
Psychotic
Disorders within Six Months after Discharge
W. Laan, Y. van
der Does,
B. Sezgi, H. M. Smeets, J. J. Stolker,
N. J.
de Wit, E. R. Heerdink
3 - Atypical
Antipsychotic Medications Are Independently Associated With
Severe Obstructive Sleep Apnea
Rishi, Muhammad Adeel;
Shetty, Mahesh; Wolff, Armand; Amoateng-Adjepong,
Yaw; Manthous, Constantine A
Clinical
Neuropharmacology: May 2010 - Volume 33 - Issue 3 - pp 109-113
3< -
Effectiveness of Switching From Aripiprazole to Ziprasidone in Patients
With Schizophrenia
Kim, Sung-Wan; Shin,
Il-Seon; Kim, Jae-Min; Bae, Kyung-Yeol; Yang,
Su-Jin; Yoon, Jin-Sang
Clinical
Neuropharmacology: May 2010 - Volume 33 - Issue 3 - pp 121-125
3 -
Lamotrigine augmentation in schizophrenia and schizoaffective patients
with obsessive-compulsive symptoms
M. Poyurovsky, I. Glick,
LM Koran
Journal of
Psychopharmacology, Vol. 24, No. 6, 861-866 (2010)
3 - Hyperprolactinemia
associated with
psychotropics - a review
Subramoniam
Madhusoodanan, Suprit Parida, Carolina Jimenez
Human
Psychopharmacology: Clinical and Experimental. Volume 25
Issue 4, Pages 281 - 297
GRATIS 3 -
Long-acting injectable antipsychotics: focus on olanzapine pamoate
JP Lindenmayer
Neuropsychiatric
Disease and Treatment. May 2010, Volume 6:261 - 267
3! -
Long-acting injectable risperidone and metabolic ratio: a possible
index of clinical outcome in treatment-resistant schizophrenic patients
Lucia Sara Volonteri,
Giancarlo Cerveri, Ilaria Francesca De Gaspari,
Maria Luisa Baldi, Maria Laura Rolandi,
Pietro Papa,
Massimo Carlo Mauri and Claudio Mencacci
Psychopharmacology. Volume
210, Number 4 / July, 2010: 489-497
| Regresar a RESÚMENES MAYO 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |